EyePoint Pharmaceuticals

About:

EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.

Website: http://www.eyepointpharma.com/

Twitter/X: EyePointPharma

Top Investors: RA Capital Management, Ocumension Therapeutics, Silicon Valley Bank, CRG, Essex Woodlands Healthcare Partners

Description:

EyePoint Pharmaceuticals develops tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. The company have developed three approved products in either the U.S. or the EU for sustained release delivery of drug utilizing multiple generations of our Durasert technology system.